Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
20101.1k citationsThomas Häuser, Raashid Luqmani et al.profile →
1994851 citationsRaashid Luqmani, P A Bacon et al.profile →
Modification and validation of the Birmingham Vasculitis Activity Score (version 3)
2008794 citationsChetan Mukhtyar, Bhaskar Dasgupta et al.Annals of the Rheumatic Diseasesprofile →
Long-term patient survival in ANCA-associated vasculitis
2010641 citationsOliver Floßmann, Annelies E. Berden et al.Annals of the Rheumatic Diseasesprofile →
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008618 citationsChetan Mukhtyar, Bhaskar Dasgupta et al.Annals of the Rheumatic Diseasesprofile →
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
2017589 citationsDavid Jayne, Peter A. Merkel et al.profile →
Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis
2005513 citationsKirsten de Groot, Niels Rasmussen et al.Arthritis & Rheumatismprofile →
EULAR recommendations for the management of large vessel vasculitis
2008431 citationsChetan Mukhtyar, Bhaskar Dasgupta et al.Annals of the Rheumatic Diseasesprofile →
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
2016296 citationsRaashid Luqmani, Bhaskar Dasgupta et al.profile →
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis with Polyangiitis
2022244 citationsPeter C. Grayson, Cristina Ponte et al.Annals of the Rheumatic Diseasesprofile →
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis
2022212 citationsJoanna Robson, Peter C. Grayson et al.Annals of the Rheumatic Diseasesprofile →
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis
2022176 citationsRavi Suppiah, Joanna Robson et al.Annals of the Rheumatic Diseasesprofile →
2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis
2022150 citationsCristina Ponte, Peter C. Grayson et al.Annals of the Rheumatic Diseasesprofile →
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Granulomatosis With Polyangiitis
2022111 citationsJoanna Robson, Peter C. Grayson et al.profile →
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis
2022110 citationsPeter C. Grayson, Cristina Ponte et al.profile →
2022 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Microscopic Polyangiitis
202295 citationsRavi Suppiah, Joanna Robson et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
Countries citing papers authored by Raashid Luqmani
Since
Specialization
Citations
This map shows the geographic impact of Raashid Luqmani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raashid Luqmani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raashid Luqmani more than expected).
This network shows the impact of papers produced by Raashid Luqmani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raashid Luqmani. The network helps show where Raashid Luqmani may publish in the future.
Co-authorship network of co-authors of Raashid Luqmani
This figure shows the co-authorship network connecting the top 25 collaborators of Raashid Luqmani.
A scholar is included among the top collaborators of Raashid Luqmani based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Raashid Luqmani. Raashid Luqmani is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Robson, Joanna, Peter C. Grayson, Cristina Ponte, et al.. (2021). 2020 American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for Eosinophilic Granulomatosis With Polyangiitis. Annals of the Rheumatic Diseases.1 indexed citations
Robson, Joanna, A. Kiran, Andrew Hutchings, et al.. (2015). Cardiovascular and Cerebrovascular Disease and Social Deprivation in Patients with Giant Cell Arteritis. Arthritis & Rheumatism. 67.1 indexed citations
8.
Miller, Anne, et al.. (2013). The Diagnostic Accuracy Of Rheumatoid Factor Testing In Primary Care. Oxford University Research Archive (ORA) (University of Oxford). 65.2 indexed citations
9.
Jayne, David, Peter Höglund, Kerstin Westman, et al.. (2012). THE DISEASE CHARACTERISTICS OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS. Nephrology. 17. 45–45.4 indexed citations
10.
Béresniak, Ariel, Jürgen Braun, Paolo Angelo Cortesi, et al.. (2012). Treat-to-Target in Rheumatoid Arthritis: Clinical and PharmacoEconomic Considerations. Clinical and Experimental Rheumatology. 30.3 indexed citations
11.
Luqmani, Raashid, et al.. (2009). BIMODAL MORTALITY RISK IN WEGENER'S GRANULOMATOSIS. Lara D. Veeken. 117. 160–160.1 indexed citations
12.
Suppiah, Ravi, Neil Basu, RA Watts, & Raashid Luqmani. (2009). Advances in the classification of primary systemic vasculitis. UEA Digital Repository (University of East Anglia).1 indexed citations
Häuser, Thomas, Raashid Luqmani, Chen Au Peh, et al.. (2009). Randomized trial of rituximab vs cyclophosphamide for ANCA-associated renal vasculitis: RITUXVAS. Apmis. 117. 78–78.7 indexed citations
15.
Floßmann, Oliver, Annelies E. Berden, Kirsten de Groot, et al.. (2009). Long-term survival of ANCA-associated vasculitis. Apmis. 117. 139–139.3 indexed citations
16.
Merkel, Peter A., David Cuthbertson, G S Hoffman, et al.. (2004). Comparison of disease activity measures for ANCA-associated vasculitis.. Oxford University Research Archive (ORA) (University of Oxford).4 indexed citations
17.
Luqmani, Raashid, David Jayne, & G. Gaskin. (2002). Adjunctive plasma exchange is superior to methylprednisolone in acute renal failure due to ANCA-associated glomerulonephritis.. Oxford University Research Archive (ORA) (University of Oxford). 46.32 indexed citations
18.
Luqmani, Raashid, P A Bacon, Niels Rasmussen, & David Jayne. (2001). Birmingham Vasculitis Activity Score (BVAS) for use in European multi-centre clinical trials. Lara D. Veeken. 40. 80–80.
Luqmani, Raashid, Abeed A. Pall, D. Adu, et al.. (1993). CONTROLLED TRIAL OF PULSE VS CONTINUOUS CYCLOPHOSPHAMIDE (CY) AND PREDNISOLONE (P) IN THE TREATMENT OF SYSTEMIC VASCULITIS. Oxford University Research Archive (ORA) (University of Oxford). 36.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.